Sustained therapeutic efficacy and safety of oral propafenone for treatment of chronic ventricular arrhythmias: A 2-year experience
- 1 January 1988
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 115 (1) , 92-96
- https://doi.org/10.1016/0002-8703(88)90522-4
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Efficacy of propafenone compared with quinidine in chronic ventricular arrhythmiasThe American Journal of Cardiology, 1985
- Comparison of propafenone and disopyramide for treatment of chronic ventricular arrhythmias: Placebo-controlled, double-blind, randomized crossover studyAmerican Heart Journal, 1985
- Effect of propafenone in patients with stable ventricular arrhythmiasAmerican Heart Journal, 1984
- Propafenone: A new agent for ventricular arrhythmiaJournal of the American College of Cardiology, 1984
- A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexesThe American Journal of Cardiology, 1983
- Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardiaThe American Journal of Cardiology, 1983
- Clinical pharmacology of propafenone.Circulation, 1983
- Electrophysiological and Antiarrhythmic Properties of Propafenon in Isolated Cardiac PreparationsJournal of Cardiovascular Pharmacology, 1981
- Electrophysiologic effects of propafenone on canine ischemic cardiac cellsThe American Journal of Cardiology, 1981
- Effects of propafenone on TEA-induced action potentials in vascular smooth muscle of canine coronary arteriesCellular and Molecular Life Sciences, 1980